Mar25Wed

Member News: Employment Tax Aspects of the Coronavirus Response Act

Irish Chamber member, Jim Malone, Principal at Post & Schell, P.C., has shared these timely articles from attorneys at his firm on the impact of  COVID.

http://www.postschell.com/publications/1749-coronavirus-covid–construction-contracts-legal-next-steps

http://www.postschell.com/publications/1751-president-signs-bill-requiring-employers-provide-paid-leave-employees-affected

http://www.postschell.com/publications/1752-eeoc-issues-new-guidance-managing-covid–risks-consistent-ada

http://www.postschell.com/publications/1753-workers-compensation-rights–obligations-light-forced-government-shutdow

http://www.postschell.com/publications/1755-employment-tax-aspects-coronavirus-response-act

Mar24Tue

FDA Guidance on Clinical Trials + Other Federal Updates

Many thanks to Life Sciences PA for sharing regular updates.

As the COVID-19 outbreak continues to disrupt our health care system and our day-to-day activity, we know many of our member organizations continue to pursue treatments and technologies for patients facing the coronavirus as well as many other diseases. As your research and development efforts move forward, we want to be sure you are up to date on the activity of two federal agencies with whom many of our members regularly interact – the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). While both are devoting significant resources to fight the pandemic, they are also ensuring other research and development efforts progress.

Read More